The Center for Citizen Leadership – Trademark Portfolio

Entity Type: 99

The Center for Citizen Leadership holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include THE MISSION CONTINUES and THE MISSION CONTINUES REPORTING FOR DUTY IN YOUR COMMUNITY. The owner is based in St. Louis, MO.

1141 South 7th Street

St. Louis, MO 63104

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

The Center for Citizen Leadership's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does The Center for Citizen Leadership have?

The Center for Citizen Leadership has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does The Center for Citizen Leadership file in?

The Center for Citizen Leadership files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.

What are The Center for Citizen Leadership's most well-known trademarks?

The Center for Citizen Leadership's registered trademark portfolio includes well-known marks such as THE MISSION CONTINUES and THE MISSION CONTINUES REPORTING FOR DUTY IN YOUR COMMUNITY. These are among 2 currently registered trademarks in the portfolio.

What is The Center for Citizen Leadership's trademark registration success rate?

The Center for Citizen Leadership has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.